Anthropic IPO: Who Controls the Board and Voting Power
Full research prompt
Analyze how the Anthropic IPO filing presents governance: risk factors, description of capital stock, board composition, the PBC and LTBT disclosures, exchange listing and controlled-company exemptions, and the anti-takeover provisions. Identify which statements are binding charter terms and which are policy. Summarize what analysts, governance experts, and proxy advisors (ISS, Glass Lewis) have said about it. If the filing is not publicly accessible, state that clearly and use the latest verified sources.
From Anthropic Public Benefit Corporation and Long-Term Benefit Trust Explained
The filing is public. Anthropic, PBC filed Form S-1 on October 26, 2026 (file 333-299633; accession 0001628280-26-067168) and Amendment No. 1 on November 2, 2026. Class A is proposed for the Nasdaq Global Select Market as “ANT.” Share count and price were still blank in the documents reviewed. The governance architecture below is taken from the October 26 prospectus text (cover, “Risks Related to our Governance Structure,” and the anti-takeover discussion), cross-checked against specialist readings of the same filing. The amendment updated operating results; it is not described as rewriting the control design.
What the prospectus actually sells is residual economics with almost no residual control. Two single shares, neither with economic rights, sit above the public float: Class T lets a purpose trust elect a board majority, and Class F lets seven co-founders cast 50.1% of the vote on everything else. Public Benefit Corporation (PBC) status then legally requires the board to balance profit against a charter purpose that is not profit.
The control stack: two shares, five classes, one public float
The cover calls the result “a novel capital and corporate governance structure” with “no direct public company precedent.” Immediately before the offering, Anthropic will issue one Class F share to Founder LLC, whose initial sole members are Dario Amodei, Daniela Amodei, Tom Brown, Jack Clark, Jared Kaplan, Sam McCandlish, and Christopher Olah. Benjamin Mann is not a member. That one share is entitled to 50.1% of total voting power on matters submitted to stockholders generally, including election of directors other than Class T directors, and it has no economic rights. The percentage is fixed, so later Class A issuance does not dilute founder votes. Inside the LLC, continuing founders vote one person, one vote; if a majority cannot agree, Class F is voted proportionately with Class A votes cast.
Class T, one share held by the Long-Term Benefit Trust (LTBT), generally elects and removes the Class T directors, who will be a majority of the authorized board, and otherwise does not vote on general stockholder matters and has no economic rights. Class A (the IPO stock) has one vote and pro rata dividends and liquidation rights. Class N, held primarily by strategic partners including Amazon and Google, has the same economics and no vote except where Delaware law requires a class vote; it generally converts to Class A on a transfer to an unaffiliated holder at or below 9.99%. Class E, for employees excluding co-founders, votes only on specified protective matters and has no economics.
Authorized capital in the certificate that becomes effective immediately before the offering is 300 billion Class A, 100 billion Class N, 30 billion Class E, 30 billion preferred, and one share each of Class F and Class T.
The prospectus states that, while both control classes exist, the LTBT and Founder LLC “will collectively have the ability to elect all members” of the board, and Class A holders “generally will not be able to affect the outcome of any matter submitted to a vote of our stockholders or the election of our directors, regardless of how they vote,” unless the continuing founders deadlock on Class F.
What this means for a buyer or a competitor: ANT is an economic claim, not a governance claim. Index funds that exclude unequal-vote or non-voting structures may be forced to pass, which the risk factors flag as a possible valuation drag. A rival that wants public-market accountability cannot copy the economics without copying, or explicitly rejecting, this split.
Board, trust, and the one real check
Post-offering the board is authorized at seven. Four Class T seats are identified as Reed Hastings (lead independent director), Vas Narasimhan, Christopher Liddell (the “Specified Class T Director”), and one vacancy. The other three, elected by Class A and Class F voting together—and therefore by Founder LLC in practice—are Dario Amodei, Daniela Amodei (chair), and Yasmin Razavi, with the filing’s director slate reflecting one vacancy in the current board as well.
The LTBT is a Delaware noncharitable purpose trust with five authorized trustees who may not hold Anthropic securities. As of the S-1, trustees are Neil “Buddy” Shah (chair; trustee since June 2023), Richard Fontaine (April 2025), Ben Bernanke (June 2026), and Christopher Stubbs (October 2026), with one seat vacant. Trustees choose their own successors. The prospectus says each trustee is paid $400,000 a year in cash, plus $25,000 for the chair, not tied to profits or to any corporate action. The trust does not run the company day to day; the board does. A board safety and risk committee is described as including Narasimhan and Liddell.
The real internal check is narrow and aimed at one seat. To replace Liddell, the Specified Class T Director, without cause, the LTBT needs the nominating and corporate governance committee’s concurrence or a Class E employee vote. Daniela Amodei sits on that committee. The LTBT cannot remove the Amodeis. That is why the trust is a board-majority mechanism, not a management-removal mechanism.
Class F has no calendar sunset. It ends if Founder LLC redeems the share or dissolves, or after a 450-day transition that starts once fewer than three continuing founders have remained for 90 consecutive days. A co-founder who retains less than 2% of their IPO-date Class A holdings can be removed from the LLC. Forbes reports that the LLC agreement, filed as an exhibit, lets each founder file a confidential ranked list of up to ten successors, approved by five of the other six; the governance committee can demand reconsideration but cannot veto an approved list. The first eight names must meet employment or public-benefit-organization criteria; the ninth and tenth need not. That succession mechanic is an LLC contract, not a charter term, but it is how Class F voting power is designed to outlive the original seven.
Ending Class T is harder. Readings of the filing describe a “Trust Amendment Threshold”: a consensual path (on the order of 80% of the board and 80% of the trustees) or, over the trustees’ objection, a stacked consent of continuing founders, Class E, and Class A. The Wall Street Journal’s reading of the objection path is: for three years after the IPO, unanimous continuing founders, a majority of employee shares voted, and a majority of Class A shares voted; thereafter, two-thirds of continuing founders, three-quarters of employee shares voted, and a majority of Class A voted; once Class F is gone, 85% of Class A outstanding. Those thresholds are charter and trust-instrument terms, not board policy.
What this means: employees are the swing constituency on one disputed Class T seat and on any attempt to kill the trust over the trustees’ objection. Public holders are not. After the founders’ special share sunsets, the trust still elects four of seven unless an extreme Class A supermajority ends it—and at that point the board itself becomes classified.
PBC status: statute, not a mission statement
Anthropic is a Delaware public benefit corporation. The amended and restated certificate of incorporation identifies the specific public benefit—the “Company Purpose”—as “the responsible development and maintenance of advanced AI for the long-term benefit of humanity.” Under DGCL §362, the corporation “shall be managed in a manner that balances” stockholders’ pecuniary interests, the best interests of those materially affected by its conduct, and that purpose. Directors are obligated, not merely permitted, to do that balancing. Under §365, a balancing decision meets the statutory duty if it is informed and disinterested and not such that no person of ordinary, sound judgment would approve. The S-1 says Anthropic cannot guarantee a conflict would be resolved in stockholders’ favor, and that judicial precedent on PBC balancing at this scale is thin.
DGCL §366 and the bylaws require a stockholder report at least every two years on performance against the public benefit. The board sets the qualitative standards; there is no third-party standard. DGCL §367 limits who can sue to enforce the balancing duty once the stock is exchange-listed: holders of the lesser of 2% of outstanding shares or $2 million in market value.
The prospectus treats several commercial choices as illustrations of that duty, not as permanent charter bans: a usage policy against fully autonomous weapons and mass surveillance; a gated Mythos preview via Project Glasswing rather than a broad release; a decision not to build image and video generation models; and planned public-benefit share issuances. Those policies can be revised. The duty to balance cannot, short of a charter amendment that itself has to clear the control structure. The company also warns that PBC status makes a hostile bid easier to reject even if it would maximize short-term yield, because new directors must weigh purpose and affected stakeholders, not only price.
Charter versus policy here: PBC status, the Company Purpose, the tripartite balancing duty, the biennial report, and the §367 standing threshold are binding (statute plus certificate and bylaws). Statements that the company “cannot assure” it will achieve the purpose, that directors “may” forgo revenue, and the current usage rules are disclosure and policy. “Financially disinterested” trustees is a structural constraint of the trust; the claim that they have the right expertise is a selection policy, not a legal standard a Class A holder can enforce.
Nasdaq listing and the controlled-company exemption
Anthropic has applied to list Class A on Nasdaq Global Select under ANT. It says it is a “controlled company” under Nasdaq rules because the LTBT, as sole holder of Class T, generally has the power to elect a majority of the authorized board—not because of Founder LLC’s 50.1%. That status permits it to opt out of:
- a majority-independent board;
- a fully independent nominating and corporate governance committee;
- a fully independent compensation committee.
The binding fact is the qualification. The choice of which exemptions to use is policy, and the prospectus is explicit about the current choice: it does not expect to rely on the exemption except for the nominating and corporate governance committee, which will not be entirely independent. The board currently has a majority of independent directors; audit and compensation committees currently consist entirely of independent directors. If it ceases to be controlled and remains listed, the nominating committee must become fully independent within Nasdaq’s transition period. Nothing in the charter locks in the current “we only use one exemption” stance. Reuters notes the practical use of that exemption: Daniela Amodei sits on the nominating committee.
What this means: controlled-company status is a consequence of Class T, so it lasts as long as the trust’s board power lasts. Investors who treat “majority independent board” as a permanent listing protection are relying on a stated intention, not a charter covenant.
Anti-takeover provisions: mostly charter, timed to the sunsets
The certificate and bylaws that become effective immediately before the offering are written as a takeover deterrent, and the risk factors say so in the company’s own words: the structure is “likely to have the effect of limiting the likelihood of an unsolicited merger proposal, unsolicited tender offer, or proxy contest for the removal of directors” and may deprive stockholders of a premium.
Provisions the filing lists as becoming effective in the charter and bylaws:
- The multi-class structure itself, so Founder LLC can determine mergers, sales, and other stockholder-approved transactions for the foreseeable future.
- Before the Class F sunset, non-Class T vacancies can be filled by the board on notice from Founder LLC, or by Class A and Class F voting together.
- Before the Class T sunset, board size can be set only with approval of 80% of authorized directors.
- Special meetings may be called only by the board (majority of authorized directors), the chair, the CEO, the president, and, before the Class F sunset, Founder LLC—not by ordinary stockholders.
- Written consent is tightly limited before both sunsets and generally barred after both sunsets (Class E actions must always be at a meeting).
- Advance-notice procedures for Class A nominations and proposals.
- No cumulative voting.
- Blank-check preferred: up to 30 billion shares, terms set by 80% of authorized directors and, before the Class F sunset, only with Founder LLC’s consent.
- After the Class F sunset, the board becomes classified into three staggered three-year classes, and 66⅔% of Class A voting power is required to amend certain charter and bylaw provisions.
- Exclusive forum: Delaware Court of Chancery (or another Delaware state or federal court) for fiduciary and DGCL claims; federal district courts for Securities Act claims; the District of Delaware for Exchange Act derivative claims. These are bylaw terms. Stockholders are not deemed to waive federal securities law.
On DGCL §203 (Delaware’s business-combination statute): the company has elected not to be governed by §203 until the later of the Class F sunset and the Class T sunset. The certificate provides that §203’s restrictions apply immediately after that later sunset. So the classic statutory anti-takeover rule is off while the special shares exist—because those shares already block a takeover—and switches on once they are gone, alongside the classified board.
Charter versus policy: every item in that list is a charter or bylaw term (or a statutory election embedded in the certificate), not a board guideline. The narrative that this is “likely” to deter bids is risk-factor disclosure of the effect of those terms. The decision to opt out of §203 only until the sunsets is itself a charter election, not a policy that management can quietly reverse without an amendment.
What outsiders have said — and what ISS and Glass Lewis have not
No public ISS or Glass Lewis report scoring this S-1, or a meeting recommendation on ANT, turned up as of November 4, 2026. That is the normal sequence: proxy advisors publish company-specific recommendations when there is a shareholder meeting, not when a preliminary prospectus drops. Their standing benchmark policies are still the relevant benchmark. ISS’s 2026 policy generally recommends voting against directors at companies with multi-class structures and unequal voting rights, with a limited exception for enhanced voting rights of limited duration. Glass Lewis is similarly skeptical of dual-class structures and of post-IPO governance terms it views as adverse to shareholders. Anthropic’s Class F has no time sunset of the sort those policies treat as curative; it sunsets only if the founder group shrinks below three or the LLC ends the share. Class T’s removal bar, once Class F is gone, is an 85% Class A vote. On those policies’ own terms, this structure would be expected to draw negative director recommendations at the first annual meeting. That is an inference from published benchmark policy, not a retrieved ISS or Glass Lewis note on Anthropic.
Named reactions that are on the record:
- Aswath Damodaran called the combination of the PBC charter and the voting design “so deviously self-serving that it would put Kim Jong Un to shame,” and said it “effectively emasculates public investors.” He distinguishes it from Alphabet and Meta, where he has owned dual-class stock, because those structures do not also give directors a legal duty to subordinate returns.
- Mark Levine, New York City comptroller (pension assets he oversees are reported above $325 billion; the office told Reuters the funds had about $7 million of private-equity exposure to Anthropic), had already asked Dario Amodei on October 14 to pause the IPO over safety, governance, and pace. After the S-1, he told Bloomberg the filing raised new concerns and described “a very worrisome trend of disempowerment to shareholders and all the balance of power tipping towards management,” comparing it unfavorably even to SpaceX. He also said the city funds would likely still get index exposure.
- Gil Luria (D.A. Davidson) called the seven-person controlling bloc an “unusual permutation” versus the one- or two-founder model at Google, and said the PBC—directors deciding what “benefit of humanity” means—is the part of the S-1 that will take longest to absorb. Mark Mahaney (Evercore ISI) wrote that governance limits shareholder influence because the board must weigh mission alongside returns, the trust elects a majority, and the co-founders hold 50.1%.
- Law professors quoted by The Verge: Elizabeth Pollman (Penn) called it a unique structure “creatively designed for this founder-led and mission-driven company.” Dorothy Lund (Columbia) said Founder LLC means the founders effectively choose the three non-trust directors. Jens Dammann (Texas) called trust control of four of seven seats highly unusual and said founders plus the trust have “tremendous power” to prioritize safety over commercial pressure. Ann Lipton (Colorado) agreed that ordinary shareholders cannot select the board or make business decisions, then added the constraint the charter does not remove: Anthropic still needs capital, so market reality may force commercial pace even if the ballot box cannot.
- Lawrence Hamermesh, a Delaware PBC specialist, told CNBC the duty “to balance” is, in practice, “Good luck,” and that a company that must keep raising capital will still have to attend to investors—while the PBC adds “another dimension of uncertainty.”
- Jan Messerschmidt (Cohen Milstein) told Law360 that founder control fixed for as long as members hold 2% of IPO-date holdings is something he had not seen; “protection of shareholders will come from disclosure, liability and fiduciary duty law, not the ballot box,” and the fiduciary law here is “largely uncharted.”
What this means for anyone underwriting or competing: the sophisticated critique is not that the disclosure is thin. It is that the binding terms (Class F at a fixed 50.1%, Class T board majority, PBC balancing with a weak enforcement standing rule, §203 off until both sunsets, classified board after the founders leave) make the ballot box irrelevant, and that the “we will only use one Nasdaq exemption” and “trustees are the right experts” statements are intentions sitting on top of those terms. The investor protection that remains is securities-law disclosure and an unsettled PBC fiduciary standard, plus the capital-markets constraint Lipton flags: a company that must keep funding compute cannot ignore the price of its stock even if it can ignore its stockholders’ votes.
Recent Findings Supplement (November 2026)
Anthropic, PBC publicly filed its Form S-1 registration statement with the SEC on October 26, 2026 (amended November 2, 2026), making the full prospectus—including governance details—publicly accessible via EDGAR.[1][2]
This filing (under CIK 0002130357, file number 333-299633) details plans to list Class A common stock on Nasdaq under ticker “ANT,” with Goldman Sachs and Morgan Stanley as lead underwriters. The initial public offering targets the week of November 16, 2026 (subject to change), potentially one of the largest ever. The document spans hundreds of pages with extensive risk factor disclosures (over 90 pages in the initial filing) and describes a multi-class capital structure and governance framework designed to balance commercial growth with the company’s AI safety mission.[3][4]
Capital Stock Classes and Voting Control
Anthropic’s post-IPO capital structure uses five classes of common stock, with control concentrated in two single shares rather than dispersed economic ownership. Class A shares (sold to the public and most existing holders) carry one vote per share and full economic rights (pro rata dividends and liquidation). Class T (one share held by the Long-Term Benefit Trust) primarily enables election/removal of a board majority. Class F (one share held by Founder LLC, owned by the seven co-founders) carries 50.1% of total voting power on most matters submitted to stockholders generally; new issuances do not dilute this percentage. Class N shares (primarily for strategic partners like hyperscalers) have no voting rights except where Delaware law requires a class vote and carry economic rights similar to Class A. Class E shares (for non-founder employees) have limited voting rights on specified matters.[5][6]
These provisions, including the creation and rights of the special classes, are embedded in the Certificate of Incorporation (charter exhibits in the S-1, such as EX-3.1), making them binding charter terms amendable only by the required stockholder vote (subject to the existing control structure). Operational details around the LTBT and Founder LLC (e.g., trustee selection processes or internal voting within the LLC) appear in supporting documents like bylaws or trust agreements, functioning more as policy or contractual arrangements layered on the charter framework.[7]
This structure ensures founders retain decisive influence on ordinary matters while the trust oversees mission alignment via board control, limiting public Class A shareholders’ practical ability to affect outcomes regardless of their aggregate ownership.[5]
Board Composition, LTBT Authority, and PBC Framework
The board has seven seats. The LTBT (an independent body with financially disinterested trustees, currently chaired by Neil “Buddy” Shah and including Ben Bernanke, Richard Fontaine, and Christopher Stubbs, with one vacancy) holds the Class T share and elects/removes four Class T directors (currently Reed Hastings, Vas Narasimhan, Christopher Liddell, and a vacancy). The founders (via Class F) elect the remaining three directors. Daniela Amodei chairs the board; Dario Amodei also serves.[8][6]
Anthropic remains a Delaware Public Benefit Corporation (PBC). Directors must balance stockholders’ pecuniary interests, the best interests of those materially affected by the company’s conduct, and the specific public benefit purpose: “the responsible development and maintenance of advanced AI for the long-term benefit of humanity.” The LTBT is explicitly designed to institutionalize this mission focus. Certain LTBT actions (e.g., removal of a specified Class T director without cause) require nominating committee concurrence or an employee vote tiebreaker mechanism. The LTBT itself can be altered or terminated only by an 85% supermajority vote in some descriptions.[9][10]
Founder control via Class F sunsets after 10 years post-IPO or when fewer than three founders remain. The staggered board (three classes serving three-year terms) activates once founder control ends, serving as an anti-takeover measure.[11]
These board election and PBC balancing requirements are primarily charter-level (via the share classes and PBC designation), while specific trustee qualifications, internal LTBT procedures, and the employee vote mechanism function as policy or bylaw-level implementations.
Nasdaq Listing, Controlled Company Status, and Anti-Takeover Features
Anthropic qualifies as a “controlled company” under Nasdaq rules because the LTBT (via Class T) has the power to elect a majority of the board. This exempts it from requirements for a majority-independent board and fully independent compensation and nominating/governance committees.[5]
Anti-takeover provisions include the dual-control structure (LTBT board majority + founder voting power), the potential for a classified/staggered board, and standard Delaware charter provisions (e.g., supermajority requirements for certain amendments once control structures lapse). The S-1 explicitly notes that the governance setup may make it more difficult to replace directors or management and could deprive stockholders of opportunities to sell at a premium.[6]
These exemptions and provisions are tied directly to the charter-defined share classes and board election mechanics.
Risk Factor Disclosures and Governance Risks
The prospectus devotes extensive space (roughly 80–94 pages) to risk factors, far beyond typical boilerplate. Key governance-related risks include potential misalignment between LTBT/founder interests and public stockholders, limited influence for Class A holders, challenges in balancing PBC duties with profitability, and uncertainties in Delaware PBC fiduciary duties (described as “largely uncharted”). AI-specific risks encompass model misalignment (e.g., self-preserving behavior resembling blackmail or resistance to shutdown), assistance to malicious actors (bioweapons, etc.), loss of human control, and geopolitical destabilization.[12][10]
These disclosures appear in the risk factors section of the prospectus (not purely charter terms) and serve as forward-looking warnings rather than binding obligations.
Analyst, Expert, and Proxy Advisor Views
As of November 4, 2026, no formal reports from ISS or Glass Lewis have surfaced in public sources (the filing is very recent, and proxy advisor commentary typically intensifies closer to or after listing). Governance experts and media analyses highlight the structure’s novelty: it has “no direct public company precedent” and layers mission-driven oversight (LTBT) with founder voting control in a way that significantly insulates the company from short-term investor pressure while raising questions about accountability to public shareholders.[13]
Commentators note the fixed 50.1% founder vote (non-dilutable and without a traditional sunset in some descriptions) and the trust’s board majority as mechanisms that prioritize long-term mission stewardship but could complicate standard governance oversight. Some view it positively as a “bold but sane” innovation for an AI company; others flag entrenchment risks and the untested nature of PBC duties in this context.[10][10]
Implications for competitors or entrants: Replicating this exact dual-control + PBC + independent trust model would require careful charter drafting and likely face scrutiny from investors and proxy advisors seeking stronger public shareholder rights. The controlled-company exemption provides flexibility on board independence but signals concentrated control that may affect valuation or institutional demand.[5]
All details above derive from the October 26/November 2, 2026 S-1 filings and contemporaneous reporting; earlier drafts or leaks predate the public filing but are superseded by the official documents.